We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.25 | 1.45% | 17.50 | 17.00 | 18.00 | 17.50 | 17.25 | 17.25 | 122,391 | 08:06:20 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.16 | 15.96M |
Date | Subject | Author | Discuss |
---|---|---|---|
12/9/2017 15:45 | However Investor Evening is being run by another organisation so Opti are just one of a number presenting, not just an Opti event. | deeppockets | |
12/9/2017 14:55 | Someuwin - If my old grey is not letting me down, the last investor event went against us. That said, I suspect there is MUCH MORE to discuss this time round. Nimrod - OPTI is still very much a trading stock for many, hence the trading range. However, there are also a lot of LTHs accumulating, sooner or later the current trading range will be left behind for higher ground. | elrico | |
12/9/2017 14:25 | Investors Evening one week today. Hoping for one or more of the big announcements to drop before then. | someuwin | |
12/9/2017 14:20 | At the end of August I thought the share price would drop to 65.5p. Maybe it will this time as I would like to buy back in again at some point....great company with more to come in the future, though still fairly volatile. | nimrod22 | |
12/9/2017 09:56 | Me also..how ever, it is difficult to judge where to buy when the the selling disengages from the news. Let's hope even more news suddenly arrives. | bobdown2 | |
12/9/2017 09:51 | Appears I should had waited with my buys. | dorset64 | |
12/9/2017 09:50 | Just zero buying to offer any support to the SP | judijudi | |
12/9/2017 09:38 | Not expecting 63.5p or 60p | john henry | |
12/9/2017 09:37 | IMHO 69.5p fib 38 or 66.5p fib 50 retracement before next leg up. | john henry | |
12/9/2017 08:50 | Morphing into 83p from our chartist is looking somewhat out of sync with the share price | judijudi | |
12/9/2017 08:36 | Hi all, Back from my jaunt in the Solent. [IMG] Anything much happened in the last week?? Only kidding, I was able to get a signal for some of the time, to keep up with the news for Opti, and Skin seems to have woken up too. All the best, John | 2350220 | |
12/9/2017 07:31 | The last time he sold was in January so hopefully he's finished for a while. | parob | |
12/9/2017 07:26 | Will he keep selling though that is the question and if he does even if it,s in a orderly manner it will hold the share price back once more Optibiotix: David Evans share sale- not an issue: BUY PUBLISHED: 11 Sep 2017 We have had a few emails about the share sale announced today by former Optibiotix (LSE:OPTI) director David Evans. Panic not. The shares are back at 72p-73p on the news: treat that as a buying opportunity. Evans has reduced his stake from 3.4% to 2.79% or 2,198,517 shares. He is not a clown so will not dump the remaining stock cackhandedly but I assume they will be sold over time. With the newsflow this company has coming it can very easily absorb that. Evans is an ex director. He is more involved with other companies and we’d be concerned if he was dumping stock in a company where he is on the board but that is not the case here. Perhaps more importantly Evans has health issues and anyone in his position would probably be selling down shares in stocks where he one was able to do so.We would and so would you. As such this is not a reflection on Optiiotix. The recent news from Tata and the promise of far bigger Tata news soon on the Slimbiome front as well as a number of other material big name deals will drive a big re-rating over the coming weeks and months. The stance remains BUY at up to 80p with a target to sell of well over 100p almost certainly in time for Christmas (2017!). | scotty1 | |
11/9/2017 19:53 | Yes Elric with the expected news flow the sellers should be cleared and hopefully we should move north sharply! | primal123 | |
11/9/2017 18:52 | Primal - Your memory is correct, David Evans did step down due to health issues, though I do think he remains active in some form elsewhere. As for whys and wherefores, people sell for many reasons, who know. Personally, I wish him well but care not for this distraction. | elrico | |
11/9/2017 17:38 | And a 50,000 sell Under the bid :( | judijudi | |
11/9/2017 16:55 | So price was walked down to fill another big buy! | primal123 | |
11/9/2017 16:41 | 175k buy reported.. largest buy seen here in a long while part from the 111,111 from parsnip. | riskybusiness1 | |
11/9/2017 16:23 | just who are these selling apart from Evans, down the pan at just above 70, back to the 60's as per norm ? | fathenry | |
11/9/2017 14:05 | Just a thought but we had a lot of buying in size going on and I just wonder if David Evans was asked to fill an order for someone to try and keep the price from running away. We all want it to go up but we had had a rise from an intraday low of circa 52p upto intraday 80p on the offer. All just my musings but won't do us any harm to stabilise around here before next big news which won't be long. Rather than it getting chased to 90p and falling back fast. Whatever the reason those 400k of shares are now in safer hands as their base is a lot higher. S | shrewdmole | |
11/9/2017 13:38 | Primal, I know, just jestin | judijudi | |
11/9/2017 13:33 | Haha JJ, it will change! Lots of news expected !! | primal123 | |
11/9/2017 13:28 | its pretty mush a risk off day across the board ...funny how you get these days with the majority are of the same mindset | onedayrodders | |
11/9/2017 13:14 | Did he not have health issues? | primal123 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions